FEDERATED HERMES, INC. - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 25 filers reported holding ATYR PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q3 2023$16,067,968
-27.0%
10,169,600
-0.2%
0.04%
-21.8%
Q2 2023$22,010,327
+2.9%
10,189,9660.0%0.06%
+1.9%
Q1 2023$21,398,929
+86.8%
10,189,966
+94.8%
0.05%
+68.8%
Q4 2022$11,457,204
-26.9%
5,231,600
+0.2%
0.03%
-30.4%
Q3 2022$15,667,000
+6.0%
5,222,2500.0%0.05%
+15.0%
Q2 2022$14,779,000
-47.1%
5,222,2500.0%0.04%
-36.5%
Q1 2022$27,939,000
-28.4%
5,222,2500.0%0.06%
-13.7%
Q4 2021$39,010,000
-17.7%
5,222,2500.0%0.07%
-18.9%
Q3 2021$47,418,000
+501.7%
5,222,250
+223.4%
0.09%
+500.0%
Q2 2021$7,881,000
+9.7%
1,615,0000.0%0.02%
+7.1%
Q1 2021$7,187,000
+14.7%
1,615,0000.0%0.01%
+7.7%
Q4 2020$6,266,000
+20.1%
1,615,0000.0%0.01%
+8.3%
Q3 2020$5,216,000
-27.3%
1,615,0000.0%0.01%
-33.3%
Q2 2020$7,171,000
+58.6%
1,615,0000.0%0.02%
+38.5%
Q1 2020$4,522,000
+82.3%
1,615,000
+171.4%
0.01%
+116.7%
Q4 2019$2,481,000
+28.9%
595,072
+8.2%
0.01%
+20.0%
Q3 2019$1,925,000550,0000.01%
Other shareholders
ATYR PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Alyeska Investment Group, L.P. 725,984$3,223,0000.05%
Marquette Asset Management, LLC 18,848$84,0000.03%
FEDERATED HERMES, INC. 1,615,000$7,171,0000.02%
VIKING GLOBAL INVESTORS LP 587,444$2,608,0000.01%
TWO SIGMA INVESTMENTS, LP 132,123$587,0000.00%
OPPENHEIMER & CO INC 18,343$81,0000.00%
Renaissance Technologies 365,830$1,624,0000.00%
TWO SIGMA ADVISERS, LP 80,950$359,0000.00%
FMR LLC 1,402,874$6,229,0000.00%
ACADIAN ASSET MANAGEMENT LLC 67,964$302,0000.00%
View complete list of ATYR PHARMA INC shareholders